Abstract: The object of the present invention is to provide a process for producing high-quality polymer microparticles having uniform particle size of the order of several micrometers to tens of micrometers by inverse suspension polymerization at high productivity while keeping excellent dispersion stability without causing aggregation among particles. The process is one for the production of polymer microparticles by inverse polymerization of a vinyl monomer and is characterized in that an oil-soluble oxidizing agent and a water-soluble reducing agent are used as a polymerization initiator and the oil-soluble oxidizing agent is fed after the water-soluble reducing agent is fed.

Abstract: [Problems] A composition curable with active energy beams for use in skin patches is provided, which is liquid at ordinary temperature, has a practical crosslinking property or curability in the absence of photopolymerization initiators even when irradiated with visible or ultraviolet light, and provides cured films that are not discolored and excellent in various pressure-sensitive adhesive performances and have appropriate pressure-sensitive adhesiveness so as not to cause pain or damage to the horny layer in the patch-applied area even when patches are repeatedly applied and peeled off, as well as excellent water resistance. [Means for solving problems] The composition curable with active energy beams for use in skin patches is liquid at ordinary temperature and comprises (A) a compound having two or more maleimide groups and (B) an oil component, or water or a water-soluble compound.

Abstract: The present invention relates to a copper-containing formulation for plant disease-control which comprises divalent copper and polyphosphate residues, wherein the amount of the polyphosphate residues per one chemical equivalent of the divalent copper is higher than one chemical equivalent. The copper-containing formulation of the present invention shows an excellent disease-control effect without causing any chemical injury of the plant.

Abstract: The present invention provides an antisense nucleic acid compound inhibiting expression of vascular endothelial growth factor as well as therapeutic and diagnostic agents comprising the same as an active ingredient. A compound which nucleotide sequence is substantially complementary to a nucleotide sequence located upstream of a translation region in a gene coding for vascular endothelial growth factor and which inhibits 50% or more of the expression of vascular endothelial growth factor in cells is used as the antisense nucleic acid.

Abstract: A matte electrodepositable coating composition and a process for preparation thereof, the composition comprising a fluorine-containing resin, an acrylic resin, an amino resin, and an aluminum complex compound, which are dissolved or dispersed in water, the fluorine-containing resin and the acrylic resin both containing a carboxyl group and a hydroxyl group in molecules thereof, the differences in acid value and hydroxyl value between the fluorine-containing resin and the acrylic resin each being not more than 50, the average acid value of the fluorine-containing resin and the acrylic resin being not less than 35, the average hydroxyl value of the fluorine-containing resin and the acrylic resin being not less than 70, the proportion of the fluorine-containing resin and the acrylic resin being in the range of 20/80 to 80/20 by weight, and the aluminum complex compound being represented by formula (1) or (2):Al(OR.sup.1)(OR.sup.2)(L) (1)Al(L.sup.1)(L.sup.2)(L.sup.3) (2)wherein R.sup.1 and R.sup.